GlassScriptPhysician profile
Andres Vega
NPI 1164528550
$1,476.62
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $672 · 2020: $435 · 2021: $369.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $458.99 | 2019-2021 | |
| Si-Bone, INC. | $165.08 | 2020 | |
| Nalu Medical, INC. | $136.50 | 2021 | |
| Amgen INC. | $134.75 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $130.38 | 2019-2021 | |
| Redhill Biopharma INC. | $105.13 | 2020-2021 | |
| Radius Health, INC. | $48.53 | 2019 | |
| Pfizer INC. | $46.38 | 2019 | |
| Grt US Holding, INC. | $42.10 | 2021 | |
| Fidia Pharma USA INC. | $40.87 | 2019 | |
| Zyla Life Sciences, INC. | $34.01 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $24.91 | 2019 | |
| Daiichi Sankyo INC. | $20.52 | 2019 | |
| Scilex Pharmaceuticals INC. | $19.81 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.74 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $19.71 | 2019 | |
| Collegium Pharmaceutical, INC. | $17.99 | 2020 | |
| Forte Bio-Pharma LLC | $11.22 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andres Vega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.